|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Booth MiM |
Denied without Interview
|
2024 | 530 GMAT Classic 720 GMAT Classic |
4 | 1 | Consulting | India |
13 Feb 2024 04:57 AM
|
|
| Full Time MBA |
Interviewed
|
Round 2 | 2024 | 695 GMAT Focus | 8.6 | 5 | Technology | Canada |
12 Feb 2024 07:39 PM
|
| Booth MiM |
Denied without Interview
|
2024 | 650 GMAT Classic | 3.4 | 0 | Technology | India |
12 Feb 2024 02:54 PM
|
|
| Full Time MBA |
Invited to Interview
|
Round 2 | 2024 | 6 | Consulting | United Kingdom |
11 Feb 2024 12:15 PM
|
||
| Full Time MBA |
Invited to Interview
|
Round 1 | 2022 | 0 | Finance | India |
10 Feb 2024 03:30 AM
|
||
| Full Time MBA |
Interviewed
|
Round 2 | 2024 | 331 GRE | 80 | 7 | Technology | India |
09 Feb 2024 10:30 AM
|
| Full Time MBA |
Invited to Interview
|
Round 2 | 2024 | 332 GRE | 3.8 | 8 | Finance: Private Equity | Pakistan |
09 Feb 2024 04:04 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 575 GMAT Focus | 8 | Finance | Pakistan |
06 Feb 2024 07:14 AM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 5 | Consulting | Canada |
05 Feb 2024 12:19 PM
|
||
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 3.6 | 1 | Finance: Private Equity | United States |
01 Feb 2024 06:37 AM
|
|
| Full Time MBA |
Invited to Interview
|
Round 2 | 2024 | 5 | Healthcare/Pharmaceuticals | United States |
31 Jan 2024 02:29 PM
|
||
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 334 GRE | 5 | Technology | India |
31 Jan 2024 01:21 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 750 GMAT Classic | 3.8 | 2 | Consulting | United States |
31 Jan 2024 11:59 AM
|
| Full Time MBA |
Admitted
|
Round 2 | 2024 | 3.8 | 7 | Finance: Venture Capital | South Africa |
31 Jan 2024 11:10 AM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 332 GRE | 3.9 | 10 | Consulting | India |
30 Jan 2024 04:12 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 334 GRE | 3.1 | 3 | Healthcare/Pharmaceuticals | India |
28 Jan 2024 11:25 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 730 GMAT Classic | 3.9 | 4 | Consulting | India |
28 Jan 2024 10:24 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 3.3 | 3 | Consulting | India |
28 Jan 2024 08:18 PM
|
|
| Executive MBA (Chicago, London, & Hongkong) |
Invited to Interview
|
2024 | 12 | Consulting | Cameroon |
28 Jan 2024 04:04 PM
|
|||
| Full Time MBA |
Invited to Interview
|
Round 2 | 2024 | 331 GRE | 3.6 | 3 | Energy | United States |
27 Jan 2024 01:39 AM
|